In vivo administration of D-arginine: Effects on blood pressure and vascular function in angiotensin II-induced hypertensive rats

Atherosclerosis

Volumn 176, Issue 2, 2004, Pages 219-225

  Wölkart, Gerald ^a   Stessel, Heike ^a   Brunner, Friedrich ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Arginine; Endothelium; Hypertension; Oxidation

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN; ANTIOXIDANT; ASCORBIC ACID; DEXTRO ARGININE; SCAVENGER; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DRUG BLOOD LEVEL; DRUG EFFECT; ENDOTHELIUM; EX VIVO STUDY; HEART MUSCLE REPERFUSION; HYPERTENSION; IN VIVO STUDY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE; VASCULAR RING;

ANGIOTENSIN II; ANIMALS; AORTA; ARGININE; DISEASE MODELS, ANIMAL; HYPERTENSION; MALE; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY; STEREOISOMERISM; VASCULAR RESISTANCE;

EID: 5644227601     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.05.016     Document Type: Article

References (30)

1. Palmer R.M.J., Rees D.D., Ashton D.S., Moncada S. L-Arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun. 153:1988;1251-1256
2. Goumas G., Tentolouris C., Tousoulis D., Stefanadis C., Toutouzas P. Therapeutic modification of L-arginine-eNOS pathway in cardiovascular diseases. Atherosclerosis. 154:2001;255-267
3. Wu G., Meininger C.J. Arginine nutrition and cardiovascular function. J Nutr. 130:2000;2626-2629
4. Tapiero H., Mathé G., Couvreur P., Tew K.D. Free amino acids in human health and pathologies. I. Arginine. Biomed Pharmacother. 56:2002;439-445
5. Li H., Wallerath T., Münzel T., Förstermann U. Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs. Nitric Oxide. 7:2002;149-164
6. Böger R.H., Bode-Böger S.M., Mügge A., et al. Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis. 117:1995;273-284
7. Clarkson P., Adams M.R., Powe A.J., et al. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. J Clin Invest. 97:1996;1989-1994
8. Adams M.R., McCredie R., Jessup W., et al. Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease. Atherosclerosis. 129:1997;261-269
9. Hishikawa K., Nakaki T., Suzuki H., Kato R., Saruta T. Role of L-arginine nitric oxide pathway in hypertension. J Hypertens. 11:1993;639-645
10. Haklar G., Ulukaya-Durakbasa Ç., Yüksel M., Dagh T., Yalçin A.S. Oxygen radicals and nitric oxide in rat mesenteric ischaemia-reperfusion: modulation by L-arginine and NG-nitro-L-arginine methyl ester. Clin Exp Pharmacol Physiol. 25:1998;908-912
11. Lass A., Suessenbacher A., Wölkart G., Mayer B., Brunner F. Functional and analytical evidence for scavenging of oxygen radicals by L-arginine. Mol Pharmacol. 61:2002;1081-1088
12. Suessenbacher A., Lass A., Mayer B., Brunner F. Antioxidative and myocardial protective effects of L-arginine in oxygen radical-induced injury of isolated perfused rat hearts. Naunyn Schmiedeberg's Arch Pharmacol. 365:2002;269-276
13. Rajagopalan S., Kurz S., Münzel T., et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation - Contribution to alterations of vasomotor tone. J Clin Invest. 97:1996;1916-1923
14. Brunner F., Wölkart G., Haleen S. Defective intracellular calcium handling in monocrotaline-induced right ventricular hypertrophy: protective effect of long-term endothelin-A receptor blockade with 2-benzo[1,3]dioxol-5-yl- 3-benzyl-4-(4-methoxy-phenyl-)-4-oxobut-2-enoate-sodium (PD 155080). J Pharmacol Exp Ther. 300:2002;442-449
15. Brunner F. Interaction of nitric oxide and endothelin-1 in ischemia/reperfusion injury of rat heart. J Mol Cell Cardiol. 29:1997;2363-2374
16. Brunner F., Wölkart G., Pfeiffer S., Russell J.C., Wascher T.C. Vascular dysfunction and myocardial contractility in the JCR:LA-corpulent rat. Cardiovasc Res. 47:2000;150-158
17. Zalba G., San José G., Moreno M.U., et al. Oxidative stress in arterial hypertension - role of NAD(P)H oxidase. Hypertension. 38:2001;1395-1399
18. Ortiz M.C., Manriquez M.C., Romero J.C., Juncos L.A. Antioxidants block angiotensin II-induced increases in blood pressure and endothelin. Hypertension. 38(Pt. 2):2001;655-659
19. Chen X., Touyz R.M., Park J.B., Schiffrin E.L. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension. 38:2001;606-611
20. Opie L.H. Reperfusion injury and its pharmacological modification. Circulation. 80:1989;1049-1062
21. Vaziri N.D., Wang X.Q., Oveisi F., Rad B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension. 36:2000;142-146
22. Hong Y.-L., Yeh S.-L., Chang C.-Y., Hu M.-L. Total plasma malondialdehyde levels in 16 Taiwanese college students determined by various thiobarbituric acid tests and an improved high-performance liquid chromatography-based method. Clin Biochem. 33:2000;619-625
23. Giugliano D., Ceriello A., Paolisso G. Oxidative stress and diabetic vascular complications. Diab Care. 19(3):1996;257-267
24. Indik J.H., Goldman S., Gaballa M.A. Oxidative stress contributes to vascular endothelial dysfunction in heart failure. Am J Physiol. 281:2001;H1767-H1770
25. Griendling K.K., Minieri C.A., Ollerenshaw J.D., Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 74:1994;1141-1148
26. Mollnau H., Wendt M., Szöcs K., et al. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res. 90:2002;e58-e65
27. Schmidt K., Klatt P., Mayer B. Characterization of endothelial cell amino acid transport systems involved in the actions of nitric oxide synthase inhibitors. Mol Pharmacol. 44:1993;615-621
28. Brandes R.P., Brandes S., Böger R.H., Bode-Böger S.M., Mügge A. L-Arginine supplementation in hypercholesterolemic rabbits normalizes leukocyte adhesion to non-endothelial matrix. Life Sci. 66:2000;1519-1524
29. Wascher T.C., Posch K., Wallner S., et al. Vascular effects of L-arginine: anything beyond a substrate for the NO-synthase? Biochem Biophys Res Commun. 234:1997;35-38
30. de Saram K., McNeill K.L., Khokher S., Ritter R.M., Chowienczyk P.J. Divergent effects of vitamin C on relaxations of rabbit aortic rings to acetylcholine and NO-donors. Br J Pharmacol. 135:2002;1044-1050